SEARCHING
The FNR is looking for a Programme/Innovation Manager to strengthen our team within the Innovation and R&D Programmes and to contribute to the further development of our innovation-driven management processes. The position is permanent (CDI), full-time, with an application deadline of Friday, 26 June 2020.
We understand that researchers and research teams may go through a difficult period triggered by the COVID-19 lockdown. Research projects may currently be suspended and key parts of projects may have to be postponed for a significant amount of time, FNR wishes to offer flexibility in the handling of grants and grant proposals.
In an international project with pharma company Sprint Bioscience, scientists at the Luxembourg Institute of Health (LIH), led by Dr Bassam Janji, have developed an approach that turns “cold” tumours “hot”, making them responsive to immunotherapy.
The FNR is pleased to announce a new RESCOM Call for proposals. Deadline to submit proposals is Tuesday, 30 June 2020, 14:00 CET.
In a collaboration with pharma company Sprint Bioscience, researchers at the Luxembourg Institute of Health (LIH), have developed an innovative approach to improve cancer immunotherapy by turning “cold” tumours “hot”.
Excessive use of fertilisers in agriculture has led to nitrogen pollution, and calls for bio substitutes are getting louder. PhD candidate Bella Tsachidou from Luxembourg Institute of Science and Technology (LIST) gathers scientific evidence on the benefits of biogas residues and their suitability as biofertilisers, while providing support for the modification of nitrogen-policies on European and global level.
In the current situation of legal uncertainty, PhD candidate Antonio Ancora’s research at the University of Luxembourg aims to improve tax certainty in the context of state aid investigation on Transfer Pricing transactions among multinational enterprises.
A team of scientists at the Luxembourg Institute of Health (LIH), led by FNR ATTRACT Fellow Prof Dirk Brenner, have discovered a novel mechanism through which the immune system can control autoimmunity and cancer. The findings set a new direction for the development of future treatments of metabolic diseases. In a nod to the significance of the findings, the research graces the cover of the journal ‘Cell Metabolism’.
